ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization

被引:169
作者
DiDonato, M
Craig, L
Huff, ME
Thayer, MM
Cardoso, RMF
Kassmann, CJ
Lo, TP
Bruns, CK
Powers, ET
Kelly, JW
Getzoff, ED
Tainer, JA
机构
[1] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
关键词
ALS; Lou Gehrig's disease; superoxide dismutase; aggregation; neurodegenerative;
D O I
10.1016/S0022-2836(03)00889-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many point mutations in human Cu,Zn superoxide dismutase (SOD) cause familial amyotrophic lateral sclerosis (FALS), a fatal neurodegenerative disorder in heterozygotes. Here we show that these mutations cluster in protein regions influencing architectural integrity. Furthermore, crystal structures of SOD wild-type and FALS mutant H43R proteins uncover resulting local framework defects. Characterizations of beta-barrel (H43R) and dimer interface (A4V) FALS mutants reveal reduced stability and drastically increased aggregation propensity Moreover, electron and atomic force microscopy indicate that these defects promote the formation of filamentous aggregates. The filaments resemble those seen in neurons of FALS patients and bind both Congo red and thioflavin T, suggesting the presence of amyloid-like, stacked beta-sheet interactions. These results support free-cysteine-independent aggregation of FALS mutant SOD as an integral part of FALS pathology. They furthermore provide a molecular basis for the single FALS disease phenotype resulting from mutations of diverse side-chains throughout the protein: many FALS mutations reduce structural integrity, lowering the energy barrier for fibrous aggregation. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:601 / 615
页数:15
相关论文
共 76 条
  • [41] Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293
  • [42] Formation of high molecular weight complexes of mutant Cu,Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis
    Johnston, JA
    Dalton, MJ
    Gurney, ME
    Kopito, RR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (23) : 12571 - 12576
  • [43] Kato S, 2001, ACTA NEUROPATHOL, V102, P233
  • [44] Klunk WE, 1999, METHOD ENZYMOL, V309, P285
  • [45] The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid
    Lai, ZH
    Colon, W
    Kelly, JW
    [J]. BIOCHEMISTRY, 1996, 35 (20) : 6470 - 6482
  • [46] LeVine H, 1999, METHOD ENZYMOL, V309, P274
  • [47] Copper(2+) binding to the surface residue cysteine 111 of His46Arg human copper-zinc superoxide dismutase, a familial amyotrophic lateral sclerosis mutant
    Liu, HB
    Zhu, HN
    Eggers, DK
    Nersissian, AM
    Faull, KF
    Goto, JJ
    Ai, JY
    Sanders-Loehr, J
    Gralla, EB
    Valentine, JS
    [J]. BIOCHEMISTRY, 2000, 39 (28) : 8125 - 8132
  • [48] MCREE DE, 1990, J BIOL CHEM, V265, P14234
  • [49] XtalView Xfit - A versatile program for manipulating atomic coordinates and electron density
    McRee, DE
    [J]. JOURNAL OF STRUCTURAL BIOLOGY, 1999, 125 (2-3) : 156 - 165
  • [50] NATVIG DO, 1987, J BIOL CHEM, V262, P14697